Pharma C Investments Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Toby Shillito
Chief executive officer
UK£26.8k
Total compensation
| CEO salary percentage | 97.0% |
| CEO tenure | 2.3yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -UK£145k |
| Mar 31 2023 | n/a | n/a | -UK£197k |
| Dec 31 2022 | UK£27k | UK£26k | -UK£250k |
| Sep 30 2022 | n/a | n/a | -UK£322k |
| Jun 30 2022 | n/a | n/a | -UK£394k |
| Mar 31 2022 | n/a | n/a | -UK£455k |
| Dec 31 2021 | UK£19k | UK£10k | -UK£517k |
Compensation vs Market: Toby's total compensation ($USD33.49K) is below average for companies of similar size in the UK market ($USD344.28K).
Compensation vs Earnings: Toby's compensation has increased whilst the company is unprofitable.
CEO
Toby Shillito (53 yo)
2.3yrs
Tenure
UK£26,806
Compensation
Mr. Toby Waldock Shillito serves as an Acting Chief Executive Officer at Pharma C Investments PLC since 2022 and served as its Director since June 25, 2021 until December 20, 2022. Mr. Shillito served as C...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Investment Strategy Director & Director | 3.8yrs | UK£57.00k | 0.76% £ 9.3k | |
| Member of Medicinal Cannabis Technical Advisory Board | no data | no data | no data | |
| Non-Executive Director | 1.2yrs | no data | no data | |
| Member of Medicinal Cannabis Technical Advisory Board | no data | no data | no data | |
| Member of Medicinal Cannabis Technical Advisory Board | no data | no data | no data | |
| Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data |
0.3yrs
Average Tenure
46.5yo
Average Age
Experienced Board: MCAI's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.